← Back to Search

Ultrasound for Pregnancy

N/A
Waitlist Available
Led By Cristian Arzola, MD
Research Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes
Awards & highlights

Study Summary

This trial is investigating if trained anesthesiologists can safely assess stomach content in pregnant patients by ultrasound to reduce the risk of complications during surgery.

Eligible Conditions
  • Aspiration Pneumonia
  • Pregnancy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antral cross-sectional area (right lateral decubitus)
Antral cross-sectional area (supine position)
Secondary outcome measures
Gastric volume (right lateral decubitus)
Gastric volume (supine position)
Grading of stomach contents
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Gastric UltrasoundExperimental Treatment1 Intervention
Ultrasound measurements of the antrum will be recorded.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~1950

Find a Location

Who is running the clinical trial?

Samuel Lunenfeld Research Institute, Mount Sinai HospitalLead Sponsor
127 Previous Clinical Trials
11,207 Total Patients Enrolled
Cristian Arzola, MDPrincipal InvestigatorMOUNT SINAI HOSPITAL
4 Previous Clinical Trials
323 Total Patients Enrolled

Media Library

Gastric Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT05946447 — N/A
Aspiration Pneumonia Research Study Groups: Gastric Ultrasound
Aspiration Pneumonia Clinical Trial 2023: Gastric Ultrasound Highlights & Side Effects. Trial Name: NCT05946447 — N/A
Gastric Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT05946447 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current research initiative admitting participants who are 25 years or older?

"This medical trial is looking for volunteers aged between 18 and 50 years to participate."

Answered by AI

Is there presently a need for participants in this experiment?

"Per the information located on clinicaltrials.gov, this research trial is actively enrolling participants as of July 6th 2023 (last updated). It was first made public on July 1st 2023."

Answered by AI

Are there any eligibility requirements that would bar my participation in this research study?

"Candidates intending to be included in this medical trial must not only have a negative pregnancy test, but also lie between 18 and 50 years of age. Currently, the research team is seeking about 30 participants."

Answered by AI

What is the maximum capacity of participants for this trial?

"Affirmative. The information on clinicaltrials.gov verifies that this research project is actively searching for test subjects, having been posted July 1st 2023 and updated recently on the 6th of July 2023. This endeavor requires 30 patients to be recruited from a single center."

Answered by AI

What objectives are the researchers hoping to accomplish with this experiment?

"The primary outcome for this experiment, which will be observed over a 5 minute period, is Antral cross-sectional area (right lateral decubitus). As secondary objectives, Gastric volume (ml) calculated from the antral cross-section; Inter-rater reliability between 3 measurements; and Grading scale of stomach contents in both supine and right lateral decubitus positions are also being monitored."

Answered by AI
~17 spots leftby May 2025